Overview

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

Status:
Recruiting

Trial end date:
2027-06-30

Target enrollment:

Participant gender:

Summary

The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy for the treatment of Gram-Negative BloodStream Infection (GN-BSI) is as effective but safer than remaining on intravenous (IV) antibiotic therapy for the duration of treatment.

Phase:

N/A

Details

Lead Sponsor:

Johns Hopkins University

Collaborator:

Patient-Centered Outcomes Research Institute

Treatments:

Anti-Bacterial Agents
Antibiotics, Antitubercular